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Abstract
Background: Ureaplasmas are among the most common bacteria isolated from the human urogenital tract.
Ureaplasmas can produce asymptomatic infections or disease characterized by an exaggerated inflammatory
response. Most investigations have focused on elucidating the pathogenic potential of Ureaplasma species, but
little attention has been paid to understanding the mechanisms by which these organisms are capable of
establishing asymptomatic infection.
Methods: We employed differential proteome profiling of bladder tissues from rats experimentally infected with U.
parvum in order to identify host cell processes perturbed by colonization with the microbe. Tissues were grouped
into four categories: sham inoculated controls, animals that spontaneously cleared infection, asymptomatic urinary
tract infection (UTI), and complicated UTI. One protein that was perturbed by infection (filamin A) was used to
further elucidate the mechanism of U. parvum-induced disruption in human benign prostate cells (BPH-1). BPH-1
cells were evaluated by confocal microscopy, immunoblotting and ELISA.
Results: Bladder tissue from animals actively colonized with U. parvum displayed significant alterations in actin
binding proteins (profilin 1, vinculin, a actinin, and filamin A) that regulate both actin polymerization and cell
cytoskeletal function pertaining to focal adhesion formation and signal transduction (Fisher’s exact test, P < 0.004;
ANOVA, P < 0.02). This phenomenon was independent of clinical profile (asymptomatic vs. complicated UTI). We
selected filamin A as a target for additional studies. In the BPH-1 model, we confirmed that U. parvum perturbed
the regulation of filamin A. Specifically, infected BPH-1 cells exhibited a significant increase in filamin A
phosphorylated at serine
2152 (P ≤ 0.01), which correlated with impaired proteolysis of the protein and its normal
intracellular distribution.
Conclusion: Filamin A dynamics were perturbed in both models of infection. Phosphorylation of filamin A occurs
in response to various cell signaling cascades that regulate cell motility, differentiation, apoptosis and inflammation.
Thus, this phenomenon may be a useful molecular marker for identifying the specific host cell pathways that are
perturbed during U. parvum infection.
Background
Ureaplasma parvum and U. urealyticum are among
the most common bacteria isolated from the human
urogenital tract [1-3]. Infection rates as high as 40 to
80% in women and up to 50% in men have been
reported [3]. Most infections of the lower urogenital
tract appear to be asymptomatic [1]. However, both
species of Ureaplasma are also responsible for a vari-
e t yo fd i s e a s e ss u c ha sc h o r i oamnionitis, spontaneous
abortion, premature birth, stillbirth, postpartum endo-
metritis, neonatal neuropathies, and pneumonia with
bronchopulmonary dysplasia [1,2,4,5]. Ureaplasmas are
also implicated in a wide range of urinary tract dis-
eases including urinary tract infection (UTI) [6],
encrusted cystitis [7], urethritis [8], chronic prostatitis
[9], and urolithiasis [10]. Most investigations have
focused on elucidating the pathogenic potential of
Ureaplasma species, but little attention has been paid
to understanding the mechanisms by which these
organisms are capable of establishing asymptomatic
infection.
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UTI that has provided some insights into the host fac-
tors associated with asymptomatic infection and compli-
cated disease [11-13]. Specifically, genetically inbred
Fisher (F344) rats that were experimentally inoculated
with U. parvum developed three clinical outcomes.
Approximately one third of inoculated animals sponta-
neously cleared infection from the urinary tract by 2
weeks post inoculation. The animals that remained
infected exhibited two distinct clinical profiles of UTI:
asymptomatic infection or infection complicated by an
exaggerated inflammatory response with bladder stone
formation as sequela [11-13]. U. parvum organisms can
be found colonizing the uroepithelial surface in both
clinical profiles of UTI. However, in animals with com-
plicated UTI, U. parvum can also be found within the
submucosa of the bladder, which may be the driving
force behind the persistent and exaggerated inflamma-
tory response.
A notable feature in animals with asymptomatic UTI
was the presence of quiescent uroepithelium despite the
presence of U. parvum, which is in contrast to what
occurs with UTI caused by other bacterial species
[14,15]. Based on our observations, we postulated that
ureaplasmas perturb uroepithelial function in a manner
that interferes with innate immune defense and supports
microbial colonization. In order to begin to identify the
host cell processes that are perturbed by Ureaplasma
during infection, we used differential proteomics to pro-
file bladder tissues from F344 rats experimentally inocu-
lated with U. parvum. Tissues from each clinical profile
(sham inoculated control, culture negative animals, ani-
mals with asymptomatic UTI, and complicated UTI
group) were analyzed in this study.
In this report we show that bladder tissue from ani-
mals actively colonized with U. parvum display signifi-
cant alterations in actin binding proteins that regulate
both actin polymerization and cell cytoskeletal function
pertaining to focal adhesion formation and signal trans-
duction. This phenomenon is independent of clinical
profile (asymptomatic vs. complicated UTI). We selected
the actin-binding protein filamin A as a target for addi-
tional studies based on proteome profiling results as
well as its integral role in cell signaling events related to
innate immunity [16,17]. We evaluated the impact of U.
parvum infection on filamin A using the benign prostate
hyperplastic (BPH-1) cell line as a model of infection. In
the BPH-1 model, we confirmed that U. parvum per-
turbed the regulation of filamin A. Specifically, infected
BPH-1 cells exhibited a significant increase in filamin A
phosphorylated at serine
2152, which correlated with
impaired proteolysis of filamin A and its intracellular
distribution.
Methods
Sample selection and protein extraction for rat bladder
proteome studies
Rat bladder tissues from animals experimentally infected
with a rat adapted strain of U. parvum were used for
differential proteome profiling [12]. All procedures were
performed in accordance with the University of Florida
Institutional Animal Care and Use Committee. Briefly,
animals were inoculated with sterile 10B broth (control
group) or 10
9 CFU of U. parvum. Tissues were collected
2 weeks post-inoculation [12]. At time of tissue harvest,
bladder from each animal was divided into 3 sections.
One section was used for histopathology, another sec-
tion was cultured for U. parvum,a n dt h et h i r ds e c t i o n
was flash frozen in liquid nitrogen and stored at -80°C
for future analysis.
For proteome studies, tissues were grouped according
to clinical profile. The negative group included animals
inoculated with 10
9 CFU of U. parvum that were culture
negative in the urinary tract at 2 weeks post inoculation
(PI). Based on acute infection studies [11], 100% of ani-
mals inoculated with this dose were infected with U.
parvum for at least 72 hours, therefore the negative
group was composed of animals that spontaneously
cleared infection. Animals within the UTI group were
culture positive at time of necropsy, had minimal histo-
logic changes in bladder tissue [12], low urine cytokine
levels, and no evidence of struvite uroliths. Animals
within the Struvite group were culture positive at time
of necropsy, had extensive histologic changes in bladder
tissue, were positive for struvites, and had marked eleva-
tions in urine pro-inflammatory cytokines. Animals
sham-inoculated with sterile 10B broth served as unin-
fected controls. In order to minimize variability of U.
parvum protein load between infected groups, only tis-
sues that had similar log CFU (2.4 to 2.7) at time of
necropsy were chosen for these experiments. Protein
from tissues was extracted with Trizol (Invitrogen
Corp., Carlsbad, CA) according to the manufacturer’s
protocol. Pelleted protein extracts were allowed to air
dry and stored at -20°C before analysis.
Quantitative proteomic analysis using peptide-labeling
and offline 2D-LC-MS/MS
Three independent iTRAQ experiments were performed.
Each experiment included one biological replicate from
a control, negative, UTI, and struvite group. Sample
processing, offline 2D-LC-MS/MS, protein identification
and quantitation were performed as previously described
[11]. Tandem mass spectra were extracted by Analyst (v
1.1.; Applied Biosystems/MDS Sciex). Concatenation of
the forward and random sequences from the IPI rat
database v 3.32 [18] were used for protein identification.
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MS/MS data interpretation algorithms from Protein
Pilot™ (Paragon™ algorithm, v 2.0, Applied Biosys-
tems/MDS Sciex) [19] and Mascot (v 2.2, Matrix
Science, London, UK). The confidence level for protein
identification was set to 1.3 (95%). The false discovery
rate for all iTRAQ™ experiments ranged from 0.0% to
0.93%. Protein ratios were generated with Pro Group™
algorithm and automatically corrected for bias. Protein
quantification was performed with a minimum of three
s p e c t r at h a tw e r ep r e s e n ti na l lp r o t e i ns a m p l e st h a t
were analyzed within the experiment. Only protein
ratios with an error factor (EF) < 2 were retained for
further analysis. EF is a measure of the variation among
the different iTRAQ™ ratios (the greater the variation,
the greater the uncertainty) and represents the 95%
uncertainty range for a reported ratio. The calculated P-
value obtained with the ProGroup™ algorithm is based
on 95% confidence interval.
Enrichment analysis of protein ratios that compared the
Negative group to animals with active infection (UTI and
Struvite groups)
Since our interest was to identify perturbations that
were present in all animals with active UTI, regardless
of the clinical profile, we only included protein ratios
that exhibited the same response to infection in all
infected groups. For example, if the protein ratio was
decreased in both UTI and Struvite groups, then that
protein was included. If the ratio was increased in the
UTI group but decreased in theS t r u v i t eg r o u p ,t h e n
that protein was considered to potentially be affected by
t h eh o s ti n f l a m m a t o r yr e s p o n s ea n dw a se x c l u d e df r o m
the analysis. Proteins were grouped according to general
biological functions as assigned in the Uniprot/Swissprot
database. Protein ratios were considered significantly dif-
ferent if they had P values less than 0.05 as determined
by the Pro Group™ algorithm; these proteins were
assigned a binary value of 1. All others ratios were con-
sidered insignificant and were assigned a binary value of
0. Fisher exact test with Bonferroni correction for multi-
ple comparisons was used to identify any biological
function categories that were significantly over or
underrepresented in animals with active UTI compared
to animals that spontaneously cleared infection. Enrich-
ment analysis was performed with JMP Genomics 3.0
software (SAS Institute Inc., Cary, NC).
ANOVA and hierarchical clustering of rat bladder tissue
proteome profiles
ANOVA was used to identify the proteome profiles that
were common among animals with active UTI but sig-
nificantly different from animals that cleared infection
(Negative group). Protein ratios comparing Negative to
control, UTI to control, and Struvite to control were
generated with the Pro Group™ algorithm. Proteome
datasets that contained only proteins with an EF < 2
and that also were identified in all three independent
iTRAQ experiments were analyzed with JMP Genomics
3.0 software (SAS Institute Inc., Cary, NC). The quality
of the data was assessed by distribution analysis, box
plots and kernel density estimates and standardized
prior to ANOVA (row by row modeling). ANOVA was
performed with a false discovery rate set at a = 0.05.
The least squares means of proteins that significantly
differed among groups (P < 0.03) were then clustered by
the method of Ward (protein to protein within group,
as well as group to group).
Infection studies with benign prostate hyperplastic cells
(BPH-1)
BPH-1 cells were a gift from Dr. Charles Rosser (MD
Anderson Cancer Center, Orlando, FL). For all experi-
ments BPH-1 cells were cultured at 37°C in 5% CO2 in
complete RPMI containing 10% fetal calf serum. For
each experiment, the number of viable cells was deter-
mined by trypan blue staining. Cell numbers were
adjusted to a concentration of 10
7 cells per ml and pla-
ted in 6 well plates (Corning Inc., Lowell, MA) or Lab-
Tek II 8 well glass slide chambers (Nuncbrand, Roche-
s t e r ,N Y ) .A f t e r2 4h o u r s ,t h e cell culture medium was
changed with fresh complete RPMI and cells were
checked for 50 to 60% confluence prior to infection
with U. parvum. Each experiment contained three biolo-
gical replicates within each treatment group, and each
experiment was repeated at least twice.
For supernatant experiments, 10 ml of RPMI medium
was harvested from BPH-1 cells that were exposed to
sterile 10B broth or 10
9 CFU of U. parvum for 24
hours. Harvested cell supernatants were first clarified by
centrifugation at 15,000 × g at 4 C for 10 minutes to
remove any cell debris. The clarified supernatant was
then filtered through sterile 0.1 μm syringe filters to
remove any bacteria. BPH-1 cell cultures were inocu-
lated with processed supernatants and maintained at 37°
C and 5% CO2 for 72 hours before harvesting.
Preparation and culture of U. parvum
For all BPH-1 cell infection experiments, our rat
adapted strain of U. parvum [13] was grown to mid log
phase (approximately 14 hours), which was confirmed
by optical density reading obtained at 550 nm. The log
CFU of each inoculum was also confirmed by culture
on A8 agar as previously described [13].
Immunocytologic assays
Anti-U. parvum rabbit polyclonal antibody (a gift from
Dr. Janet Robertson, Medical Microbiology and
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bacteria in BPH-1 cell cultures. Rabbit monoclonal anti-
body clone EP2405Y (Epitomics, Burlingame, CA) that
recognizes the C terminal region of filamin A was used
to detect intact, and cleaved forms of the molecule.
Mouse monoclonal anti-filamin 1 (clone SPM182 from
Santa Cruz Biotechnology, Inc, Santa Cruz, CA) was
used to detect the intact form of the whole molecule.
Rabbit monoclonal antibody clone EP2310AY was used
to detect Filamin A phosphorylated at serine
2152
(Abcam Inc., Cambridge, MA). Rabbit and mouse IgG
isotype controls were used to assess non-specific binding
of primary antibodies (Thermo Scientific, Fremont, CA).
For detection purposes, secondary antibodies were Alexa
Fluor-488 goat anti-mouse IgG and ALEXA Fluor-594
goat anti-rabbit IgG (Invitrogen, Corp., Carlsbad, CA).
Nuclei were stained with DAPI and polymerized actin
was stained with Phalloidin labeled with Alexa Fluor-
488 (Invitrogen, Corp., Carlsbad, CA).
Cells grown on sterile glass slides were fixed for 3
minutes with 3.7% formaldehyde in phosphate buffered
saline (PBS), and processed for immunofluorescent
staining as previously described [11]. Images were cap-
tured with Olympus IX81-DSU Spinning Disk confocal
Microscope using Slidebook software (Olympus, Center
Valley, PA).
For determination of U. parvum infection rates, foci
that demonstrated colocalization of DAPI with anti-U
parvum antibody were counted as positive. For quantifi-
cation of cells with normal intracellular filamin A distri-
bution, cells that exhibited strong intranuclear staining
of filamin A were counted as positive. For all studies, a
minimum of five biological replicates were evaluated
and at least 200 cells per sample were counted.
Preparation of whole cell lysates for ELISA
Adherent cells were gently washed twice with sterile
PBS. Cells were then lysed with 1 ml of ice cold lysis
b u f f e r[ 5 0m MT r i s ,p H7 . 5 ,0 . 1 5MN a C l ,2m M
EDTA, 1 mM EGTA, 1% Triton -X] supplemented with
HALT protease inhibitor and HALT phosphatase inhibi-
tor (PIERCE Chemicals, Rockford, IL.). Cell suspensions
were transferred to sterile tubes and sonicated with
three 10 second pulses (Sonic Dismembrator model 500,
Fisher Scientific, Pittsburgh, PA). Disrupted cell suspen-
sions were divided into 200 μl aliquots and stored at
-80°C.
Detection of total and phosphorylated filamin A by ELISA
OptEIA ELISA reagent kit B (BD Biosciences, San
Diego, CA) was used to perform the assay as previously
described [11]. Reagents used in this study were mouse
monoclonal anti-filamin 1 (clone SPM182 from Santa
Cruz Biotechnology, Inc, Santa Cruz, CA) for capture, c
terminal filamin A rabbit monoclonal (Epitomics, Bur-
lingame, CA) for detection of total filamin A, and phos-
pho
S2152 filamin A rabbit polyclonal antibody (ab75978
from Abcam Inc., Cambridge, MA) to detect the phos-
phorylated protein. For normalization purposes, the
total protein concentration of each sample was deter-
mined by micro BCA protein assay (Pierce Chemicals,
Rockwood, MD). Absorbance values (ABS) obtained by
ELISA were divided by their total protein concentration
so that values are reported as ABS/mg of total protein.
Western blot analysis
Filamin A was detected with rabbit monoclonal anti-C
terminal antibody (Epitomics, Burlingame, CA). Calpas-
tatin, calpain, and GAPDH were detected with rabbit
polyclonal antibodies (Abcam, Cambridge, MA).
GAPDH was used as a loading control. Nuclear and
cytoplasmic fractions were prepared with NE-PER
nuclear and cytoplasmic extraction kit supplemented
with HALT™ protease inhibitor and HALT™ phospha-
tase inhibitor (Thermo Scientific, Rockford, IL).
Cell extracts were loaded onto a NuPAGE
® 10% Bis-
Tris gel (Invitrogen, Carlsbad, CA) and subjected to 105
V for 1.5 hours in MOPS-SDS running buffer. Protein
transfer to nitrocellulose membrane filter paper, 0.45
μm pore size (Invitrogen, Carlsbad, CA), was performed
at 30 V for 1.5 hours in transfer buffer [Bicine 25 mM,
Bis-Tris 25 mM, EDTA 1 mM, and 10% methanol].
Detection was performed with Super Signal
® West Pico
Complete Rabbit IgG Detection Kit (Thermo Scientific,
Rockford, IL) according to manufacturer’s instructions.
Chemiluminescence was detected with ChemiDoc™
Imaging system and densitometry of imaged bands was
performed with Quantity One v 4.6.9 software (Biorad
Laboratories Inc. Hercules CA).
Statistical data analysis of BPH-1 cell experiments
Data from multiple experiments were grouped together
in order to make statistical analysis possible. Data were
analyzed by one-way ANOVA when more than two
groups were included in the analysis. Fisher’s Protected
Least Significant Difference (PLSD) test was used when
ANOVA indicated a significant difference among group
means. Unpaired student’s t test was used for compari-
sons that were limited to two groups. For all analyses, a
probability of P ≤ 0.05 was considered significant.
Results
Proteome profiling of F344 rat bladder tissues
Two approaches, enrichment analysis and ANOVA,
were used to identify proteins that displayed the same
response to U. parvum infection regardless of the clini-
cal profile (UTI or Struvite). In the first approach,
enrichment analysis was performed on protein ratios
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animals that were still actively infected with U. parvum
(both UTI and Struvite groups). Only proteins that were
identified in all three independent iTRAQ experiments
and that also exhibited a common effect among animals
actively infected with U. parvum were used for this ana-
lysis. Using these criteria, 28 of 84 proteins exhibited
b o t has i g n i f i c a n t( P<0 . 0 5 )a n dac o m m o ne f f e c tw i t h
U. parvum colonization (listed in Additional file 1,
Table S1). The distribution of these proteins according
to their biological function is summarized in Figure 1a
and 1b. Enrichment analysis revealed that animals colo-
nized with U. parvum exhibited a significant change in
proteins that regulate actin polymerization (P < 0.004,
with Bonferroni correction). These actin-regulating pro-
teins were profilin 1, filamin A, a actinin, vinculin, spec-
trin and talin. With the exception of profilin 1, all actin
binding proteins were significantly lower in animals
colonized with U. parvum (Additional File 1, Table S1).
In the second analysis, we compared the proteome pro-
file of animals inoculated with U. parvum to the pro-
teome profile from sham inoculated controls. All
protein ratios (Negative/control, UTI/control, and Stru-
vite/control) that had an EF < 2 and that were identified
in all three iTRAQ experiments were then analyzed by
ANOVA. Twenty-eight of 315 proteins displayed a
7%
7%
7%
11%
11%
11%
11%
4%
7% 3%
Endocrine 0%
Protein processing 0%
lipid 0%
Actin dynamics**22%
C A
11%
9%
2%
11%
4%
7%
14%
Protein processing 
22%
Actin dynamics 0%
Transport 0%
7%
2%
7%
4%
B
Inflammation Endocrine Apoptosis /Immunity
Extracellular matrix/Structural Signal transduction Transport
Oxidative metabolism Lipid metabolism Actin dynamics
Protein processing Translation Carbohydrate metabolism
Unclassified Genetic process
Figure 1 Proteome profiling of F344 rat tissues inoculated with sterile broth or U. parvum. Panels A and B represent the percent of
proteins assigned to each biological function group. Gene ontology designations were obtained from the Uniprot/Swissprot Database. Protein
ratios of each specific protein are from UTI and Struvite groups divided by the Negative group (n = 3). Graph A shows the distribution of
protein ratios that exhibited a significant difference by Pro Group™ algorithm (P < 0.05). **Biological function categories that were determined
to be significantly different by enrichment analysis. Graph B shows the distribution of protein ratios that were not significantly different between
Negative group and groups that were culture positive for U. parvum (UTI and Struvite). Panel C is a hierarchical cluster of standardized least
squares means that were significantly different (P < 0.02) among Negative, Struvite, and UTI groups. Ratios generated with the ProGroup™
algorithm were analyzed by ANOVA (n = 3) with a false discovery rate a = 0.05.
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Struvite groups (P < 0.03). These proteins are listed in
Additional file 1, Table S2. The least squared means of
the 28 proteins were clustered and are presented in Fig-
ure 1C. Protein clusters 5, 6, and 7 showed a similar
pattern in UTI and Struvite groups which was markedly
different from the Negative group. Cluster 5 contained
apolipoprotein A-I precursor, peptidyl-prolyl cis-trans
isomerase B precursor, and calmodulin. Cluster 6 con-
tained isocitrate dehydrogenase [NADP], EH-domain
containing 2 protein, a-enolase, peroxiredoxin-2, crea-
tine kinase B-type, and complement C3 precursor. Clus-
ter 7 contained elongation factor 1a, a-actinin, vinculin,
and filamin A.
Table 1 lists the 8 proteins found to be significantly
affected by U. parvum as detected by both enrichment
analysis and ANOVA. Four of these proteins (profilin
1, a actinin, vinculin, and filamin A) are involved in
the regulation of actin polymerization. With the
exception of profilin 1, these actin binding proteins
were significantly decreased in animals with active
infection.
Because filamin A is one of the better characterized
proteins and is involved in regulating both signal
transduction and gene expression [16,17], we chose to
focus our attention on this key protein. We evaluated
the distribution of filamin A in rat bladder tissues by
immunofluorescent staining with the monoclonal anti-
body specific for intact filamin A (see Additional file
2). There was no appreciable difference in the overall
intensity or distribution of filamin A staining in the
tissues of uninfected and infected animals. Therefore,
in order to further characterize the effect of U. parvum
colonization on filamin A dynamics of host cells, it was
necessary to expand our studies to a cell culture
system.
Infection of human BPH-1 cells with U. parvum
We established a model of infection using the BPH-1
immortalized, differentiated epithelial cell line [20,21].
In addition to being amenable to chronic infection with
mycoplasmas [22], prostate cells exhibit a distinct intra-
cellular distribution of filamin A that facilitates evaluat-
ing its dynamics [22].
In preliminary studies, the frequency of U. parvum
colonization of BPH-1 cells was evaluated by confocal
microscopy at 24, 48, and 72 hours. In all experiments,
U. parvum organisms were consistently found on the
host cell membrane (see Additional file 3). U. parvum
colonization of BPH-1 cells was detected by both DAPI
staining and U. parvum specific antibody labeling. At 24
hours, U. parvum could be detected on 97 ± 3.5%
(mean ± SD, n = 4) of cells that were evaluated in two
separate experiments. At 48 hours, colonization rates
were reduced to 60.5 ± 15%. By 72 hours, 51 ± 7.8% of
cells were colonized. We selected the 72 hour post
inoculation time point for all additional experiments
since colonization rates appeared to stabilize by that
time point.
Intracellular distribution of filamin A in BPH-1 cells
We evaluated the intracellular distribution of filamin A
in uninfected and infected BPH-1 cells by confocal
microscopy and immunoblotting. Uninfected cells
showed a punctate pattern of filamin A within the
nucleus (see Figure 2a) that was seen only with the
antibody that recognized the cleaved form of filamin
A. When a monoclonal antibody that recognized only
intact filamin A was used, nuclear filamin A appeared
to be present in a striated form that resembled actin
stress fibers. This was confirmed with co-localization
studies of filamin A with polymerized actin as shown
in Additional file 3. This intracellular distribution of
Table 1 List of proteins found to be perturbed in animals with active U. parvum infection
a).
Accession
b) Protein name Gene Ontology Biological Process
c) Effect
d)
IPI00194097.5 Gc Vitamin D-binding protein transports vitamin D and its metabolites ↑
IPI00193485.2 Isocitrate dehydrogenase
[NADP]
carbohydrate metabolism ↓
IPI00767147.1 Similar to Alpha-enolase carbohydrate metabolism ↓
IPI00195372.1 Elongation factor 1-alpha 1 protein biosynthesis/translational elongation ↓
IPI00231358.6 Profilin - 1 actin binding ↑
IPI00454431.1 Brain-specific alpha actinin 1 actin binding ↓
IPI00365286.3 Similar to Vinculin cell motility/cell adhesion/lamellipodium biogenesis ↓
IPI00409539.3 Similar to Filamin-A actin filament binding/actin cytoskeleton reorganization/glycoprotein binding/cytoplasmic
sequestering of protein/regulation of transcription factor/regulation of I-kappa b kinase/NF-
b cascade
↓
a) Proteins found to be significantly altered by both enrichment analysis (Figure 1A and B) and ANOVA (Figure 1b).
b) Accession numbers refer to the International Protein Database, http://www.ebi.ac.uk/IPI/IPIhelp.html.
c) Gene ontology data was obtained from the Panther database http://www.pantherdb.org and the UniprotKB/Swiss-Prot Database http://www.ebi.ac.uk/uniprot.
d) Effect refers to the protein ratio that was generated by the ProGroup™ algorithm, which compared actively infected animals (UTI and Struvite groups) to
Negative group or Control group. Actual protein ratios are listed in Additional file 1, tables S1 and S2.
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Page 6 of 13Figure 2 Intracellular distribution intact and cleaved filamin A in BPH-1 cells. Cells were exposed to sterile 10B broth, 10
9 CFU of U.
parvum (UP), or cell culture supernatant (super) for 72 hours before examination by confocal microscopy (A), Western blot (B) and densitometry
(C). Confocal images were taken at 600× magnification and the scale bar is equal to 10 μm. Cleaved and intact filamin A (Fil A) were stained
with rabbit- anti C terminal filamin A (red). Intact Fil A was stained with mouse anti-filamin 1 (green). BPH-1 nuclei and U. parvum (white arrow)
were identified with DAPI stain (blue). Western blot analysis for the detection of cleaved filamin A was performed on cytosolic (cyt) and nuclear
(nuc) fractions from uninfected (BPH) and infected (UP) cells. The black arrow is delineating GAPDH, which was used as a loading control and a
confirmation that the nuclear fraction was not contaminated with cytosolic proteins. Quantitation of intact filamin A was performed by
densitometry of the cytosolic fractions of uninfected and U. parvum infected cells. The average quantity within each blot was normalized by
dividing the average quantity of filamin A protein band by the average quantity of the GAPDH band. Values represent the mean ± SD of 3
replicates from 3 independent experiments.
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mal prostate cells [23,24]. Interestingly, a significant
proportion of U. parvum infected BPH-1 cells exhib-
ited a marked reduction in the punctate nuclear stain-
ing of filamin A coupled with a concurrent increased
of filamin A in the cytosol (P < 0.0001). Specifically, 68
± 10% of U. parvum infected cells as compared with
14.4 ± 4% of uninfected cells showed this abnormal
phenotype.
In order to determine if the abnormal filamin A phe-
notype could be the result of a paracrine mediated host
response to infection, we exposed BPH-1 cells to culture
supernatants obtained from sham inoculated or U. par-
vum infected cultures. Supernatants were harvested
from BPH-1 cell cultures at 24 hours post inoculation
with U. parvum. The 24 hour time point was chosen
because cell culture supernatants obtained at this post
inoculation time point contain the highest cytokine/che-
mokine concentrations (unpublished studies in our
laboratory). Moreover, we wanted to minimize any
potential confounding factors that could result from
incubating cells with nutrient depleted medium, which
could occur if a longer post inoculation time point was
selected. As shown in the two bottom panels in Figure
2a, supernatant treated cultures did not display an
abnormal filamin A phenotype as was detected in U.
parvum infected cultures.
We evaluated both nuclear and cytosolic fractions of
cell lysates by Western blot with the antibody that
recognizes the C-terminal portion of filamin A. As
shown in Figure 2b, there was a marked reduction in
the detection of filamin A fragments in lysates from U.
parvum infected cultures. Densitometry of intact filamin
A in the cytosolic fraction of cell lysates was also per-
formed (Figure 2c). For this analysis, ratios were gener-
ated by dividing the average quantity of intact filamin A
by the average quantity of GAPDH that was used as a
loading control. As shown in Figure 2c, the relative
amount of intact filamin A was greater in the cytosolic
fraction of U. parvum infected cells. The total amount
of filamin A was also measured by ELISA, and no signif-
icant difference in the total amount of filamin A among
infected and uninfected BPH-1 cells was detected (data
not shown).
Detection of phosphorylated filamin A in BPH-1 cells
In prostate cells, a dominant pathway of filamin A regu-
lation involves cleavage of the protein by calpain [23,24].
Calpain mediated cleavage of filamin A can be reduced
by phosphorylation of the protein at serine
2152.T h e r e -
fore, we assessed the degree of filamin A phosphoryla-
tion at serine
2152 by immunofluorescent microscopy
(Figure 3A) and ELISA (Figure 3B). Both detection
methods confirmed that only cells infected with U.
parvum displayed a significant increase in phosphory-
lated filamin A.
Detection of calpastatin and calpain in BPH-1 cells
Recent studies have shown that infection of host cells
with Mycoplasma hyorhinis caused inhibition of calpain
activity through upregulation of its inhibitor, calpastatin
[25]. Therefore, we also evaluated the effect of U. par-
vum infection on the intracellular distribution and the
relative concentrations of calpain and calpastatin in
BPH-1 cells. We did not detect a difference in the intra-
cellular distribution of calpain among uninfected BPH-1
cells, U. parvum infected cells, and cells incubated with
supernatants by confocal microscopy (data not shown).
We also did not observe any appreciable differences in
the amount of calpain present within the cytosolic and
nuclear fractions of these cells by Western blot (data
not shown). However, we did observe differences in
both the intracellular distribution of calpastatin and its
relative concentration among the groups. Specifically, U.
parvum infected cells exhibited large aggregates of cal-
pastatin within the nucleus, and these aggregates were
more prominent than what was observed in the other
groups (Figure 4A). Moreover, Western blot showed
that calpastatin was reduced in the cytosolic fraction of
U. parvum infected cells (Figure 4B), which was con-
firmed by densitometry (Figure 4C.)
Discussion
In our previous study, we found that colonization of the
mucosal surface of the bladder was a common feature
in inbred F344 rats with either asymptomatic or compli-
cated UTI [12]. Based on these findings, we postulated
that U. parvum may be causing a disruption in epithelial
host cell function in a manner that supports microbial
colonization. In order to identify host cell proteins that
may be perturbed by U. parvum colonization, we used
differential proteome profiling to compare animals with
active UTI to animals that spontaneously cleared infec-
tion or with sham inoculated controls. We used both
enrichment analysis and ANOVA to identify correla-
tions between colonization with U. parvum and pertur-
bations in functional protein categories or protein
networks. Both methods revealed that animals colonized
with U. parvum exhibited significant perturbations in
proteins that normally regulate actin polymerization
during cell attachment, motility and signal transduction
events [26-31]. Specifically, the concentration of profilin
1, a actinin, vinculin, and filamin A were found to be
significantly altered by infection.
We chose to focus our additional experiments on fila-
min A because its regulation has been studied more
extensively than that of profilin 1, a actinin, and vincu-
lin [16,17,23,24,26]. This protein is also involved in the
Allam et al. BMC Infectious Diseases 2011, 11:101
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Page 8 of 13Figure 3 Intracellular distribution and quantification of phosphorylated filamin A in uninfected, U. parvum infected, and supernatant
treated BPH-1 cells. Cells were exposed to sterile 10B broth, 10
9 CFU of U. parvum, or cell culture supernatant (super) for 72 hours before
examination by confocal microscopy (A), or ELISA (B). Phosphorylated filamin A (red) was detected with a rabbit monoclonal antibody
(EP2310AY). Intact filamin A (green) was detected with mouse anti-filamin 1. BPH-1 nuclei and U. parvum (white arrow) were identified with DAPI
stain (blue). All images were taken at 600× magnification and the scale bar is equal to 10 μm. ELISA for phosphorylated filamin A was performed
on whole cell lysates. Absorbance values were divided by the total mg protein determined by BCA assay. Values represent the mean ± SD (n =
5) of phosphorylated filamin A in uninfected (BPH-1) and infected (UP), uninfected supernatant treated (BPH super), and infected supernatant
treated (UP super) cells. **P Value Was obtained by Fishers PLSD.
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Page 9 of 13Figure 4 Intracellular distribution and quantification of calpastatin in uninfected, U. parvum infected, and supernatant treated BPH-1
cells. Cells were exposed to sterile 10B broth, 10
9 CFU of U. parvum, or cell culture supernatant for 72 hours before examination by confocal
microscopy (A), Western blot (B) and densitometry (C). Confocal images were taken at 600× magnification and the scale bar is equal to 10 μm.
Calpastatin was detected with rabbit polyclonal antibody (red). BPH-1 nuclei and U. parvum (white arrow) were identified with DAPI stain (blue).
Western blot analysis for the detection of calpastatin was performed on cytosolic (cyt) and nuclear (nuc) fractions from uninfected cells (BPH),
infected (UP), uninfected supernatant treated (BPH S) and infected supernatant treated (UP S) cells. M equals molecular weight marker. GAPDH
was used as a loading control and a confirmation that the nuclear fraction was not contaminated with cytosolic proteins. Quantitation of
calpastatin in cytosolic fractions was performed by densitometry. The average quantity within each blot was normalized by dividing the average
quantity of calpastatin protein band by the average quantity of the GAPDH band within each blot. Values represent the mean ± SD of 2
biological replicates from 2 independent experiments.
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Page 10 of 13regulation of various cell signaling events including
pathways that are important in both innate and adaptive
immunity [32-35]. According to the ProGroup™ analy-
sis, filamin A was significantly reduced in animals
actively colonized with U. parvum.H o w e v e r ,i m m u n o -
fluorescent detection of filamin A in rat bladder tissues
did not support the proteome data. Thus, the changes
that we observed in infected tissues may be a reflection
of post-translational events such as proteolysis or che-
mical modifications that affect protein solubility and
recovery during protein extraction [27,28]. Therefore, it
was necessary to develop an in vitro model of infection
that could be used to elucidate these mechanisms. BPH-
1 cells were used as our model system because they are
a differentiated, immortalized epithelial cell line of the
urogenital tract [20,21] that is amenable to long-term
colonization with Mollicutes [22]. Moreover, prostate
cells display a distinct intracellular distribution of fila-
min A that we were able to exploit in our studies
[23,24]. Specifically, filamin A cleavage mediated by cal-
pain is a dominant pathway in prostate cells. Once fila-
min A is cleaved, the C - terminal fragments of the
protein translocate to the nucleus [23,24]. We observed
C - terminal fragments of filamin A within the nucleus
of uninfected cells by confocal microscopy. We also
observed these fragments within the cytosolic fraction of
BPH-1 cells by Western blot. However, we did not
detect these fragments within the nuclear fraction of
these cells by this method, which is most likely a reflec-
tion of the detection limits of the assay. Despite this
limitation, both confocal microscopy and Western blot
identified a disruption in the normal process of filamin
A cleavage in U. parvum infected cells. This effect
appears to be due to the actual presence of the microbe
since it was not observed in cells exposed to cell culture
supernatants from infected cultures.
Two principle mechanisms can account for the
decreased proteolysis of filamin A. The protein itself
becomes resistant to calpain mediated cleavage when it
is phosphorylated at serine
2152 [36,37]. The second
mechanism involves direct inhibition of calpain by its
natural inhibitor calpastatin [38,39]. Changes in intracel-
lular concentrations of calpain and calpastatin have
been shown to correlate with changes in filamin A clea-
vage [40]. The results of our studies suggest that phos-
phorylation of filamin A is the most likely mechanism
for U. parvum mediated disruption in this system. U.
parvum infected cells had significantly greater amounts
of filamin A phosphorylated at serine
2152 than did the
other groups (uninfected cells or cells incubated with
supernatants). U. parvum infection did not appear to
affect the intracellular distribution of calpain or its over-
all concentration as detected by Western blot. Further-
more, the changes we observed in calpastatin dynamics
of U. parvum infected cells could actually reduce the
ability of calapstatin to inhibit calpain [41,42].
Phosphorylation of filamin A may be a downstream
effect of signal transduction that is initiated at the host
cell membrane/microbe interface. Both cAMP-depen-
dent kinase (PKA) [37] and ribosomal S6 kinase (RSK)
[43] have been reported to endogenously phosphorylate
filamin A at serine
2152. Therefore, both kinases are
potential upstream effectors of U. parvum mediated
effects on filamin A. However, our results suggest the
cAMP pathway may be the more likely target of U. par-
vum infection. For example, the perturbation of calpas-
tatin dynamics observed in infected BPH-1 cells can
occur with increased intracellular cAMP and activation
of PKA [41]. The changes in vinculin, a actinin, a eno-
lase, and elongation factor 1a that were detected by dif-
ferential proteome profiling of bladder tissues can also
be the result of increased intracellular cAMP [44-47].
Downstream effectors of cAMP such as EPAC
(exchange protein directly activated by cAMP, also
known as cAMP-GEF) and PKA have been shown to
modulate inflammation and tissue proliferation [48,49].
Thus, elucidating the upstream components of filamin
A phosphorylation may provide new mechanistic
insights into the mechanisms of ureaplasmal asympto-
matic infection and disease.
The effects we observed in U. parvum infected BPH-1
cells can provide an explanation for the reduction of
filamin A that was detected in the iTRAQ experiments.
The phosphorylation of filamin A that was noted in U.
parvum infected cells correlated with its redistribution
into less soluble compartments of BPH-1 cells (cell
membrane and the cell cytoskeleton). Since less soluble
proteins can be lost by Trizol extraction methods, they
can be underrepresented within the fraction and mea-
sured as a decrease by iTRAQ™ analysis. Unfortunately,
none of the available antibodies specific for phosphory-
lated filamin A at serine
2152 worked in rat bladder tis-
sues so we could not determine if this also occurred in
infected animals. Despite these limitations, both models
of infection displayed a perturbation of filamin A
dynamics, which may serve as a viable molecular marker
for delineating the host cell signal transduction path-
ways that are affected by U. parvum infection.
Conclusions
Proteome profiling of rat bladder tissues identified a sig-
nificant perturbation in host cell filamin A during colo-
nization with U. parvum. In vitro infection studies with
BPH-1 cells confirmed that U. parvum colonization
interfered with the normal distribution of intracellular
filamin A by inducing phosphorylation of the protein at
serine
2152. Phosphorylation of filamin A occurs in
response to various cell signaling cascades that regulate
Allam et al. BMC Infectious Diseases 2011, 11:101
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Page 11 of 13cell motility, differentiation, apoptosis and inflammation,
which may be relevant to ureaplasmal disease pathogen-
esis. Thus, this phenomenon may be a useful molecular
marker for identifying the specific host cell signaling
pathways perturbed during U. parvum infection.
Additional material
Additional file 1: Table S1 - Rat bladder proteins that were
significantly altered by active infection with U. parvum as
determined with the Pro Group™™ algorithm. Table S1 contains the
list of protein ratios that significantly differed among rats inoculated with
U. parvum (active infection versus cleared infection). Results are
presented as the mean ± SD of three biological replicates obtained from
three independent iTRAQ™™ experiments. Ratios were generated by
dividing the spectral intensity value in UTI and Struvite groups by the
spectral intensity for a specific peptide in the Negative group. Only
protein ratios that showed a similar response in both UTI and Struvite
groups and were significantly different from the Negative group (P <
0.05) are listed. Proteins were grouped according to their assigned
biological function. Table S2 - Rat bladder tissue proteome profiles
that were significantly different among rats inoculated with U.
parvum as determined by ANOVA. Table S2 contains the list of protein
ratios obtained with the ProGroup™™ algorithm (mean ± SD) that were
significantly different among rats inoculated with U. parvum as
determined by ANOVA. Data was obtained from three biological
replicates from three independent iTRAQ™™ experiments. Protein ratios
were generated by dividing the spectral intensity of the protein in a U.
parvum inoculated group (Negative, UTI, or Struvite) with the spectral
intensity in the sham inoculated control using the ProGroup™™
algorithm. Proteins that showed a significantly different profile (P < 0.03)
are listed. Proteins are grouped according to the cluster pattern shown
in Figure 1C that was obtained by the method of Ward. The biological
function of each protein was obtained from the Panther database http://
www.pantherdb.org or the Rat Genome Database http://rgd.mcw.edu/
wg.
Additional file 2: Immunohistochemical detection of intact filamin A
in the bladder tissue of F344 rats inoculated with sterile 10B broth
or 10
9 CFU of U. parvum. Representative bladder tissue sections from
isotype primary antibody control (A), sham inoculated control (B),
asymptomatic UTI (C), and struvite (D) groups demonstrating the
distribution of intact filamin A (green). Nuclei were stained with DAPI
(blue). Images are 600× magnification, L = bladder lumen, SM =
submucosa, and arrows are pointing to uroepithelium.
Additional file 3: Colocalization of filamin A with polymerized actin
in uninfected and U. parvum infected BPH-1 cells. Representative
images of cells examined 72 hours after inoculation with sterile 10B
broth or 10
9 CFU of U. parvum. Nuclei were stained with DAPI (blue),
white arrows are pointing to U. parvum colonies that were detected with
DAPI staining. Filamin A (Fil A) was stained with rabbit- anti C terminal
filamin A (red). Polymerized actin was stained with phalloidin Alexa-448
(green). All images were taken at 400× magnification and the scale bar is
equal to 10 μm.
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